HF
IART icon

HRT Financial’s Integra LifeSciences IART Stock Holding History

HRT Financial’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-102,921
Closed -$1.28M – 4206
2025
Q4 		$1.28M Buy
+102,921
New +$1.37M ﹤0.01% 1577
2024
Q4 		– Sell
-32,764
Closed -$595K – 2767
2024
Q3 		$595K Buy
+32,764
New +$759K ﹤0.01% 1507
2024
Q1 		– Sell
-51,235
Closed -$2.23M – 2638
2023
Q4 		$2.23M Buy
+51,235
New +$2.02M 0.02% 606
2023
Q3 		– Sell
-64,322
Closed -$2.65M – 2703
2023
Q2 		$2.65M Buy
+64,322
New +$3.1M 0.02% 492
2022
Q4 		– Sell
-52,148
Closed -$2.21M – 2760
2022
Q3 		$2.21M Buy
52,148
+29,669
+132% +$1.52M 0.02% 569
2022
Q2 		$1.21M Sell
22,479
-29,740
-57% -$1.79M 0.01% 801
2022
Q1 		$3.35M Buy
52,219
+39,137
+299% +$2.58M 0.02% 418
2021
Q4 		$876K Buy
+13,082
New +$885K 0.01% 1243
2020
Q3 		– Sell
-14,910
Closed -$700K – 2097
2020
Q2 		$700K Buy
+14,910
New +$733K 0.02% 655
2019
Q4 		– Sell
-5,789
Closed -$347K – 1371
2019
Q3 		$347K Sell
5,789
-7,239
-56% -$431K 0.02% 863
2019
Q2 		$727K Buy
13,028
+9,410
+260% +$485K 0.05% 329
2019
Q1 		$201K Buy
+3,618
New +$184K 0.03% 395

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HRT Financial's IART Position: Q1 2026 in Review

HRT Financial sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 102,921 shares — an estimated $1.28M sold.

HRT Financial first reported a position in IART in Q1 2019 and held it in 12 quarters. The position peaked at $3.35M in Q1 2022. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • HRT Financial reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 102,921 Integra LifeSciences shares in Q1 2026, an estimated $1.28M.
  • HRT Financial first reported a position in Integra LifeSciences in Q1 2019 and held it in 12 quarters.
  • HRT Financial's Integra LifeSciences position peaked at $3.35M in Q1 2022.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.